136 related articles for article (PubMed ID: 7191492)
1. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
3. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
Ryberg B; Pirskanen R
Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. A pilot study.
Khatri BO; Koethe SM; McQuillen MP
Arch Neurol; 1984 Jul; 41(7):734-8. PubMed ID: 6234867
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
7. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
Cendrowski W
Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
[No Abstract] [Full Text] [Related]
8. [Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
Losy J; Karolewska J; Wender M
Neurol Neurochir Pol; 1996; 30(2):201-11. PubMed ID: 8756247
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: current concepts and management.
Arnason BG
Hosp Pract (Off Ed); 1982 Feb; 17(2):81-9. PubMed ID: 6210614
[No Abstract] [Full Text] [Related]
10. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis.
Uccelli A; Capello E; Fenoglio D; Incagliato M; Valbonesi M; Mancardi GL
Ital J Neurol Sci; 1994 Feb; 15(1):51-3. PubMed ID: 8206747
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
Staugaitis SM; Shapshak P; Myers LW; Ellison GW; Tourtellotte WW; Lee M
Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytapheresis therapy in multiple sclerosis, a preliminary study.
Medaer R; Eeckhout C; Gautama K; Vermijlen C
Acta Neurol Scand; 1984 Aug; 70(2):111-5. PubMed ID: 6485745
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects.
Hauser SL; Fosburg M; Kevy SV; Weiner HL
Neurology; 1984 Jul; 34(7):922-6. PubMed ID: 6539868
[TBL] [Abstract][Full Text] [Related]
15. The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
Lamers KJ; Uitdehaag BM; Hommes OR; Doesburg W; Wevers RA; von Geel WJ
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1334-7. PubMed ID: 2465387
[TBL] [Abstract][Full Text] [Related]
16. Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease.
Dau PC
J Neuroimmunol; 1990 Nov; 30(1):15-21. PubMed ID: 2229403
[TBL] [Abstract][Full Text] [Related]
17. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
[TBL] [Abstract][Full Text] [Related]
18. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
[TBL] [Abstract][Full Text] [Related]
19. Isoprinosine in multiple sclerosis treatment: a preliminary study.
Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
[TBL] [Abstract][Full Text] [Related]
20. [Plasmapheresis in multiple sclerosis].
Fuchs S; Pogglitsch H; Ladurner G; Lechner H
Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
